サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1664753

男性ホルモン補充療法の世界市場レポート 2025年

Testosterone Replacement Therapy Global Market Report 2025

出版日
ページ情報
英文 200 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.03円
男性ホルモン補充療法の世界市場レポート 2025年
出版日: 2025年02月27日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

男性ホルモン補充療法の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR2.1％で22億8,000万米ドルに成長します。予測期間の成長は、精密医療へのアプローチ、男性ウェルネス市場の拡大、規制支援、医療サービスの世界化、健康とフィットネスの動向、社会的態度の変化に起因すると考えられます。予測期間の主な動向には、送達システムの革新、遠隔医療と遠隔モニタリング、カスタマイズされた治療計画、栄養とライフスタイルのアプローチ、併用療法の調査などが含まれます。

男性ホルモン補充療法市場は、性腺機能低下症としても知られるテストステロン欠乏症の有病率の増加により成長が見込まれます。性腺機能低下症は、体内で十分な量のテストステロンを生成できないテストステロンレベルの低下を特徴とします。男性ホルモン補充療法は、テストステロンレベルを生理的範囲内に上昇させ、性欲減退、勃起不全、抑うつ気分、貧血、筋肉減少などの症状を緩和するために使用されます。例えば、2022年にWestern Michigan Urological Associatesが発表した報告書によると、米国では約1,300万人の男性、つまり30歳以上の男性の4人に1人がテストステロン値の低下に苦しんでいることが明らかになった。このことは、テストステロン欠乏症の発生率が増加していることを強調し、男性ホルモン補充療法市場の拡大に寄与しています。

老人人口の増加が、今後数年間の男性ホルモン補充療法市場の成長を牽引すると予測されています。老年人口とは、一般的に65歳以上の高齢者を指します。この層向けの男性ホルモン補充療法は、ホルモンバランスを最適化し、高齢者の幸福感と機能的健康を高めることを目的としています。例えば、2022年10月、スイスに本部を置く保健専門機関である世界保健機関（WHO）は、2030年までに世界の6人に1人が60歳以上になると報告し、2050年までに高齢者の数は21億人に達すると予測しています。その結果、老人人口の増加が男性ホルモン補充療法市場の成長に拍車をかけています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界男性ホルモン補充療法PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、制約）
  • 最終用途産業の分析
  • 世界の男性ホルモン補充療法市場：成長率分析
  • 世界の男性ホルモン補充療法市場の実績：規模と成長, 2019-2024
  • 世界の男性ホルモン補充療法市場の予測：規模と成長, 2024-2029, 2034F
  • 世界男性ホルモン補充療法総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界の男性ホルモン補充療法市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • オーラル
  • インプラント
  • ジェルまたはクリーム
  • パッチ
  • 頬粘膜接着剤
  • 非経口
  • その他の製品
  • 世界の男性ホルモン補充療法市場適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 性腺機能低下症
  • 自己免疫疾患
  • 遺伝性疾患
  • 性器手術
  • その他の適応症
  • 世界の男性ホルモン補充療法市場有効成分の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • テストステロン
  • メチルテストステロン
  • テストステロンウンデカン酸
  • テストステロンエナンセート
  • テストステロンシピオネート
  • 世界の男性ホルモン補充療法市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院
  • クリニック
  • その他のエンドユーザー
  • 世界の男性ホルモン補充療法市場、口腔のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • タブレット
  • カプセル
  • 世界の男性ホルモン補充療法市場、インプラントの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ペレット
  • 世界の男性ホルモン補充療法市場、ジェルまたはクリームの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 経皮吸収ゲル
  • 経皮クリーム
  • 世界の男性ホルモン補充療法市場、パッチのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 経皮パッチ
  • 世界の男性ホルモン補充療法市場、頬粘膜接着剤の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • バッカル錠
  • 世界の男性ホルモン補充療法市場、非経口剤のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 筋肉内注射
  • 皮下注射
  • 世界の男性ホルモン補充療法市場、その他の製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 鼻スプレー
  • その他の配送方法

第7章 地域別・国別分析

  • 世界の男性ホルモン補充療法市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の男性ホルモン補充療法市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 男性ホルモン補充療法市場：競合情勢
  • 男性ホルモン補充療法市場：企業プロファイル
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Acerus Pharmaceuticals Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Antares Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bayer Aktiengesellschaft Overview, Products and Services, Strategy and Financial Analysis
    • BioTE Medical LLC Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Clarus Therapeutics Inc.
  • Eli Lilly and Company
  • Endo International plc
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Limited
  • Acrux Limited
  • Actiza Pharmaceutical Inc.
  • Aytu BioPharma Inc.
  • Cipla Limited
  • Sun Pharmaceutical Industries Limited
  • Ferring Pharmaceuticals Holdings S.A.
  • Mylan N.V.
  • Bausch Health Companies Inc.
  • Allergan plc
  • Sandoz International GmbH

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 男性ホルモン補充療法市場2029：新たな機会を提供する国
  • 男性ホルモン補充療法市場2029：新たな機会を提供するセグメント
  • 男性ホルモン補充療法市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r23795

Testosterone replacement therapy is a hormonal treatment method utilized to address low testosterone (T) levels in males, commonly associated with aging or certain medical conditions.

The primary types of testosterone replacement therapy include oral formulations, implants, gels or creams, patches, buccal adhesives, parenteral administration, and other delivery methods. Oral administration involves intake through the mouth via tablets, capsules, syrups, or similar forms. Low testosterone indications encompass conditions such as hypogonadism, autoimmune disorders, genetic abnormalities, sex organ surgeries, and other related issues. Various active ingredients are employed in treating such conditions, including testosterone, methyl testosterone, testosterone undecanoate, testosterone enanthate, and testosterone cypionate. These therapies are administered by various end-users, including hospitals, clinics, and other healthcare facilities.

The testosterone replacement therapy market research report is one of a series of new reports from The Business Research Company that provides testosterone replacement therapy market statistics, including testosterone replacement therapy industry global market size, regional shares, competitors with a testosterone replacement therapy market share, detailed testosterone replacement therapy market segments, market trends and opportunities, and any further data you may need to thrive in the testosterone replacement therapy industry. This testosterone replacement therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The testosterone replacement therapy market size has grown steadily in recent years. It will grow from $2.04 billion in 2024 to $2.1 billion in 2025 at a compound annual growth rate (CAGR) of 2.7%. The growth in the historic period can be attributed to rising incidence of hypogonadism, increased life expectancy, changing lifestyles, prevalence of diabetes and metabolic syndrome, patient preference for non-invasive therapies, growing male infertility concerns.

The testosterone replacement therapy market size is expected to see steady growth in the next few years. It will grow to $2.28 billion in 2029 at a compound annual growth rate (CAGR) of 2.1%. The growth in the forecast period can be attributed to precision medicine approaches, increasing male wellness market, regulatory support, globalization of health services, health and fitness trends, changing societal attitudes. Major trends in the forecast period include innovations in delivery systems, telemedicine and remote monitoring, customized treatment plans, nutritional and lifestyle approaches, research on combination therapies.

The testosterone replacement therapy market is anticipated to experience growth due to the increasing prevalence of testosterone deficiency, also known as hypogonadism. Hypogonadism is characterized by low testosterone levels, where the body is unable to produce an adequate amount of testosterone. Testosterone replacement therapy is employed to elevate testosterone levels within the physiological range, addressing the effects of hypogonadism and alleviating symptoms such as reduced libido, erectile dysfunction, depressed mood, anemia, muscle loss, and more. For instance, a report by Western Michigan Urological Associates in 2022 highlighted that approximately 13 million men in the United States, equivalent to 1 in 4 males over the age of 30, suffer from low testosterone levels. This underscores the growing incidence of testosterone deficiency, contributing to the expansion of the testosterone replacement therapy market.

The increasing geriatric population is projected to drive the growth of the testosterone replacement therapy market in the coming years. The geriatric population refers to older adults, typically defined as those aged 65 and above. Testosterone replacement therapy for this demographic aims to optimize hormonal balance, enhancing well-being and functional health among older individuals. For example, in October 2022, the World Health Organization, a Switzerland-based specialized health agency, reported that by 2030, 1 in 6 individuals globally will be 60 or older, with the number of elderly people expected to reach 2.1 billion by 2050. Consequently, the rising geriatric population is fueling the growth of the testosterone replacement therapy market.

Major companies in the testosterone replacement therapy (TRT) market are increasingly focusing on innovative delivery methods, such as oral formulations and telemedicine platforms, to offer men with low testosterone levels accessible and effective treatment options that improve overall health and well-being. PRIME is an oral testosterone replacement therapy (TRT) product designed to provide a non-invasive alternative to traditional injectable therapies for men with low testosterone levels. For example, in March 2024, Mangoceuticals Inc., a US-based company that specializes in men's health and wellness products, launched 'PRIME', an oral testosterone replacement therapy (TRT) powered by Kyzatrex, which is approved by the Food and Drug Administration, a US health agency. Kyzatrex is an oral formulation of testosterone undecanoate intended to treat adult males with conditions associated with hypogonadism. This development represents a significant advancement in treating adult males suffering from hypogonadism, a condition marked by low testosterone levels, positioning PRIME as a convenient option for individuals seeking effective TRT alternatives.

There is a growing emphasis on testosterone cypionate injections among major companies in the testosterone replacement therapy market. Testosterone cypionate is a synthetic form of the male sex hormone testosterone and is commonly prescribed as part of testosterone replacement therapy to address conditions associated with testosterone deficiency. In April 2023, Xiromed LLC launched Testosterone Cypionate Injection (USP), providing a new option for males with low testosterone or related conditions such as erectile dysfunction or hypogonadism. This injectable form of testosterone is recognized for its effectiveness in restoring testosterone levels to a healthy range, making it a valuable solution for hormone replacement therapy, especially for individuals experiencing symptoms of testosterone deficiency.

In October 2022, Tolmar Pharmaceuticals Inc., a US-based pharmaceutical company specializing in testosterone therapy, acquired Clarus Therapeutics Inc. for an undisclosed amount. This acquisition is intended to enhance Tolmar Pharmaceuticals Inc.'s portfolio in urology and men's health by incorporating JATENZO, a testosterone replacement therapy developed by Clarus Therapeutics Inc. Clarus Therapeutics Inc. is a US-based company engaged in testosterone replacement therapy.

Major companies operating in the testosterone replacement therapy market include AbbVie Inc., Acerus Pharmaceuticals Corporation, Antares Pharma Inc., Bayer Aktiengesellschaft, BioTE Medical LLC, Clarus Therapeutics Inc., Eli Lilly and Company, Endo International plc, Pfizer Inc., Teva Pharmaceutical Industries Limited, Acrux Limited, Actiza Pharmaceutical Inc., Aytu BioPharma Inc., Cipla Limited, Sun Pharmaceutical Industries Limited, Ferring Pharmaceuticals Holdings S.A., Mylan N.V., Bausch Health Companies Inc., Allergan plc, Sandoz International GmbH, Perrigo Company plc, Besins Healthcare

North America was the largest region in the testosterone replacement therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the testosterone replacement therapy market report during the forecast period. The regions covered in the testosterone replacement therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the testosterone replacement therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The testosterone replacement therapy market includes revenues earned by entities by providing hormone testing, semen analysis, pituitary imaging, genetic studies, and testicular biopsy to treat low testosterone deficiency. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Testosterone Replacement Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on testosterone replacement therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for testosterone replacement therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The testosterone replacement therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Oral; Implants; Gel Or Creams; Patches; Buccal Adhesive; Parenteral; Other Products
  • 2) By Indication: Hypogonadism; Autoimmune Conditions; Genetic Disorders; Sex Organ Surgeries; Other Indications
  • 3) By Active Ingredient Type: Testosterone; Methyl Testosterone; Testosterone Undecanoate; Testosterone Enanthate; Testosterone Cypionate
  • 4) By End User: Hospitals; Clinics; Other End-User
  • Subsegments:
  • 1) By Oral: Tablets; Capsules
  • 2) By Implants: Pellets
  • 3) By Gel Or Creams: Transdermal Gels; Transdermal Creams
  • 4) By Patches: Transdermal Patches
  • 5) By Buccal Adhesive: Buccal Tablets
  • 6) By Parenteral: Intramuscular Injections; Subcutaneous Injections
  • 7) By Other Products: Nasal Sprays; Other Delivery Forms
  • Companies Mentioned: AbbVie Inc.; Acerus Pharmaceuticals Corporation; Antares Pharma Inc.; Bayer Aktiengesellschaft; BioTE Medical LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Testosterone Replacement Therapy Market Characteristics

3. Testosterone Replacement Therapy Market Trends And Strategies

4. Testosterone Replacement Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Testosterone Replacement Therapy Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Testosterone Replacement Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Testosterone Replacement Therapy Market Growth Rate Analysis
  • 5.4. Global Testosterone Replacement Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Testosterone Replacement Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Testosterone Replacement Therapy Total Addressable Market (TAM)

6. Testosterone Replacement Therapy Market Segmentation

  • 6.1. Global Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Implants
  • Gel Or Creams
  • Patches
  • Buccal Adhesive
  • Parenteral
  • Other Products
  • 6.2. Global Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hypogonadism
  • Autoimmune Conditions
  • Genetic Disorders
  • Sex Organ Surgeries
  • Other Indications
  • 6.3. Global Testosterone Replacement Therapy Market, Segmentation By Active Ingredient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Testosterone
  • Methyl Testosterone
  • Testosterone Undecanoate
  • Testosterone Enanthate
  • Testosterone Cypionate
  • 6.4. Global Testosterone Replacement Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Other End-User
  • 6.5. Global Testosterone Replacement Therapy Market, Sub-Segmentation Of Oral, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tablets
  • Capsules
  • 6.6. Global Testosterone Replacement Therapy Market, Sub-Segmentation Of Implants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pellets
  • 6.7. Global Testosterone Replacement Therapy Market, Sub-Segmentation Of Gel Or Cream, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transdermal Gels
  • Transdermal Creams
  • 6.8. Global Testosterone Replacement Therapy Market, Sub-Segmentation Of Patches, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transdermal Patches
  • 6.9. Global Testosterone Replacement Therapy Market, Sub-Segmentation Of Buccal Adhesive, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Buccal Tablets
  • 6.10. Global Testosterone Replacement Therapy Market, Sub-Segmentation Of Parenteral, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Intramuscular Injections
  • Subcutaneous Injections
  • 6.11. Global Testosterone Replacement Therapy Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nasal Sprays
  • Other Delivery Forms

7. Testosterone Replacement Therapy Market Regional And Country Analysis

  • 7.1. Global Testosterone Replacement Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Testosterone Replacement Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Testosterone Replacement Therapy Market

  • 8.1. Asia-Pacific Testosterone Replacement Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Testosterone Replacement Therapy Market, Segmentation By Active Ingredient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Testosterone Replacement Therapy Market

  • 9.1. China Testosterone Replacement Therapy Market Overview
  • 9.2. China Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Testosterone Replacement Therapy Market, Segmentation By Active Ingredient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Testosterone Replacement Therapy Market

  • 10.1. India Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Testosterone Replacement Therapy Market, Segmentation By Active Ingredient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Testosterone Replacement Therapy Market

  • 11.1. Japan Testosterone Replacement Therapy Market Overview
  • 11.2. Japan Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Testosterone Replacement Therapy Market, Segmentation By Active Ingredient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Testosterone Replacement Therapy Market

  • 12.1. Australia Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Testosterone Replacement Therapy Market, Segmentation By Active Ingredient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Testosterone Replacement Therapy Market

  • 13.1. Indonesia Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Testosterone Replacement Therapy Market, Segmentation By Active Ingredient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Testosterone Replacement Therapy Market

  • 14.1. South Korea Testosterone Replacement Therapy Market Overview
  • 14.2. South Korea Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Testosterone Replacement Therapy Market, Segmentation By Active Ingredient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Testosterone Replacement Therapy Market

  • 15.1. Western Europe Testosterone Replacement Therapy Market Overview
  • 15.2. Western Europe Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Testosterone Replacement Therapy Market, Segmentation By Active Ingredient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Testosterone Replacement Therapy Market

  • 16.1. UK Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Testosterone Replacement Therapy Market, Segmentation By Active Ingredient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Testosterone Replacement Therapy Market

  • 17.1. Germany Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Testosterone Replacement Therapy Market, Segmentation By Active Ingredient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Testosterone Replacement Therapy Market

  • 18.1. France Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Testosterone Replacement Therapy Market, Segmentation By Active Ingredient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Testosterone Replacement Therapy Market

  • 19.1. Italy Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Testosterone Replacement Therapy Market, Segmentation By Active Ingredient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Testosterone Replacement Therapy Market

  • 20.1. Spain Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Testosterone Replacement Therapy Market, Segmentation By Active Ingredient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Testosterone Replacement Therapy Market

  • 21.1. Eastern Europe Testosterone Replacement Therapy Market Overview
  • 21.2. Eastern Europe Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Testosterone Replacement Therapy Market, Segmentation By Active Ingredient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Testosterone Replacement Therapy Market

  • 22.1. Russia Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Testosterone Replacement Therapy Market, Segmentation By Active Ingredient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Testosterone Replacement Therapy Market

  • 23.1. North America Testosterone Replacement Therapy Market Overview
  • 23.2. North America Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Testosterone Replacement Therapy Market, Segmentation By Active Ingredient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Testosterone Replacement Therapy Market

  • 24.1. USA Testosterone Replacement Therapy Market Overview
  • 24.2. USA Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Testosterone Replacement Therapy Market, Segmentation By Active Ingredient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Testosterone Replacement Therapy Market

  • 25.1. Canada Testosterone Replacement Therapy Market Overview
  • 25.2. Canada Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Testosterone Replacement Therapy Market, Segmentation By Active Ingredient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Testosterone Replacement Therapy Market

  • 26.1. South America Testosterone Replacement Therapy Market Overview
  • 26.2. South America Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Testosterone Replacement Therapy Market, Segmentation By Active Ingredient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Testosterone Replacement Therapy Market

  • 27.1. Brazil Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Testosterone Replacement Therapy Market, Segmentation By Active Ingredient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Testosterone Replacement Therapy Market

  • 28.1. Middle East Testosterone Replacement Therapy Market Overview
  • 28.2. Middle East Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Testosterone Replacement Therapy Market, Segmentation By Active Ingredient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Testosterone Replacement Therapy Market

  • 29.1. Africa Testosterone Replacement Therapy Market Overview
  • 29.2. Africa Testosterone Replacement Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Testosterone Replacement Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Testosterone Replacement Therapy Market, Segmentation By Active Ingredient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Testosterone Replacement Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Testosterone Replacement Therapy Market Competitive Landscape
  • 30.2. Testosterone Replacement Therapy Market Company Profiles
    • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Acerus Pharmaceuticals Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Antares Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bayer Aktiengesellschaft Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. BioTE Medical LLC Overview, Products and Services, Strategy and Financial Analysis

31. Testosterone Replacement Therapy Market Other Major And Innovative Companies

  • 31.1. Clarus Therapeutics Inc.
  • 31.2. Eli Lilly and Company
  • 31.3. Endo International plc
  • 31.4. Pfizer Inc.
  • 31.5. Teva Pharmaceutical Industries Limited
  • 31.6. Acrux Limited
  • 31.7. Actiza Pharmaceutical Inc.
  • 31.8. Aytu BioPharma Inc.
  • 31.9. Cipla Limited
  • 31.10. Sun Pharmaceutical Industries Limited
  • 31.11. Ferring Pharmaceuticals Holdings S.A.
  • 31.12. Mylan N.V.
  • 31.13. Bausch Health Companies Inc.
  • 31.14. Allergan plc
  • 31.15. Sandoz International GmbH

32. Global Testosterone Replacement Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Testosterone Replacement Therapy Market

34. Recent Developments In The Testosterone Replacement Therapy Market

35. Testosterone Replacement Therapy Market High Potential Countries, Segments and Strategies

  • 35.1 Testosterone Replacement Therapy Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Testosterone Replacement Therapy Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Testosterone Replacement Therapy Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer